These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 2552315)
41. Ganciclovir/acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients. Harland RC; Vernon WB; Bunzendahl H; Thompson JK; Lawrence C; Bollinger RR Transplant Proc; 1994 Apr; 26(2):432-3. PubMed ID: 8171488 [No Abstract] [Full Text] [Related]
42. Acyclovir prophylaxis of cytomegalovirus disease in kidney transplant recipients. Vila A; Guirado LL; Balius A; Díaz M; Baró E; Olaya M; Andrade M; Agraz I; Solá R Transplant Proc; 1999 Sep; 31(6):2335-6. PubMed ID: 10500605 [No Abstract] [Full Text] [Related]
43. Acyclovir for cytomegalovirus infection. Selby P; Powles R; Stolle K; Stern H Br Med J (Clin Res Ed); 1984 Jul; 289(6439):253. PubMed ID: 6331564 [No Abstract] [Full Text] [Related]
44. Randomized controlled trial of acyclovir for the prevention of cytomegalovirus infection and disease in liver transplant recipients. Saliba F; Eyraud D; Samuel D; David MF; Arulnaden JL; Dussaix E; Mathieu D; Bismuth H Transplant Proc; 1993 Feb; 25(1 Pt 2):1444-5. PubMed ID: 8382876 [No Abstract] [Full Text] [Related]
45. Interferon for prevention of cytomegalovirus reactivation in renal-transplant recipients. Himmelstein DU; Woolhandler S N Engl J Med; 1983 Nov; 309(19):1193. PubMed ID: 6194436 [No Abstract] [Full Text] [Related]
53. Prophylactic acyclovir in patients receiving bone marrow transplants. Trigg ME; Finlay JL; Sondel PM N Engl J Med; 1985 Jun; 312(26):1708-9. PubMed ID: 3889644 [No Abstract] [Full Text] [Related]
54. Use of pooled immunoglobulin and acyclovir as prophylaxis against cytomegalovirus disease in recipients of renal allografts. Barton IK; Nicholson F Nephrol Dial Transplant; 1991; 6(7):525-6. PubMed ID: 1656329 [No Abstract] [Full Text] [Related]
56. Cytomegalovirus infection after transplantation: prevention is still the challenge. Reusing Junior JO; David-Neto E J Bras Nefrol; 2017; 39(4):353-354. PubMed ID: 29319758 [No Abstract] [Full Text] [Related]
57. Prevention of cytomegalovirus disease following renal transplantation. Hanshaw JB Am J Dis Child; 1977 Aug; 131(8):841-5. PubMed ID: 196502 [No Abstract] [Full Text] [Related]
58. Should renal-transplant patients be screened for C.M.V.? Lancet; 1978 Oct; 2(8093):770-1. PubMed ID: 80691 [No Abstract] [Full Text] [Related]